Структурные исследования методом МУРР аптамера к онколитическому вирусу VV-GMCSF-Lact

Oncolytic viral therapy is a relatively young but rapidly developing area in cancer therapy. Some viruses can be used to combat cancer cells due to their cytotoxic action, but it is desirable to inhibit the influence of the human immune system on them. Aptamers, short oligonucleotides capable of specifically binding to their molecular targets, can perform a dual role: binding to oncoviruses and blocking their receptors through which the immune system attacks them, and also delivering them to another target — cancer cells, to increase the effectiveness of the virus. For such a complex task, it is critically important to know the three-dimensional structure of such bifunctional molecules as aptamers. This work presents a study of the NV14t_56 aptamer to the oncolytic virus VV-GMCSF-Lact using the small-angle X-ray scattering method in solution, determination of the structural characteristics extracted using this method, and validation of the molecular model constructed on the basis of the predicted secondary structure

Authors

Publication Details

Journal
SibFU Digital Repository (Siberian Federal University)
Published
2024-10-26
Primary Topic
Virus-based gene therapy research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Структурные исследования методом МУРР аптамера к онколитическому вирусу VV-GMCSF-Lact

Vladimir A. Richter, Roman V. Moryachkov, Irina A. Shchugoreva, Daria O. Malysheva et al.
SibFU Digital Repository (Siberian Federal University)
Virus-based gene therapy research
article

Структурные исследования методом МУРР аптамера к онколитическому вирусу VV-GMCSF-Lact

Vladimir A. Richter, Roman V. Moryachkov, Irina A. Shchugoreva, Daria O. Malysheva, Anna S. Kichkailo, Дарья Малышева, Maya Dymova, Владимир А. Рихтер, Роман В. Морячков, Ирина А. Щугорева, Майя А. Дымова, Анна С. Кичкайло
article en

Abstract

Oncolytic viral therapy is a relatively young but rapidly developing area in cancer therapy. Some viruses can be used to combat cancer cells due to their cytotoxic action, but it is desirable to inhibit the influence of the human immune system on them. Aptamers, short oligonucleotides capable of specifically binding to their molecular targets, can perform a dual role: binding to oncoviruses and blocking their receptors through which the immune system attacks them, and also delivering them to another target — cancer cells, to increase the effectiveness of the virus. For such a complex task, it is critically important to know the three-dimensional structure of such bifunctional molecules as aptamers. This work presents a study of the NV14t_56 aptamer to the oncolytic virus VV-GMCSF-Lact using the small-angle X-ray scattering method in solution, determination of the structural characteristics extracted using this method, and validation of the molecular model constructed on the basis of the predicted secondary structure

SibFU Digital Repository (Siberian Federal University)
Openalex Percentile: Top 32%
Virus-based gene therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.